Business Standard

Molbio Diagnostics looking to expand test menu on its Truenat platform

The company is also open to raising funds and has been in talks with PE and VC funds for the same

Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma
Premium

Sohini Das Mumbai
Goa-based Molbio Diagnostics, which came up with a portable, battery operated RT-PCR point of care testing system that revolutionised India’s Covid-19 testing in the hinterland, is now planning to develop a plethora of tests to fuel its future growth.

Chandrasekhar Nair, Director and CTO, Molbio Diagnostics tells Business Standard that the platform can do 40 different kinds of tests now, and there are another 30 tests in the pipeline.

Covid-19 has given a big push to this young molecular diagnostic company – its revenues grew from Rs 52 crore in FY20 to Rs 1,252 crore in FY21 riding on the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in